(Reuters) - ViroPharma's HCV-796 is currently in mid-stage studies and
is being developed with drugmaker Wyeth .
Read more at Reuters.com Government Filings News
is being developed with drugmaker Wyeth .
Read more at Reuters.com Government Filings News
No comments:
Post a Comment